Angiotensin-Converting Enzyme 2 Inhibits Apoptosis of Pulmonary Endothelial Cells During Acute Lung Injury Through Suppressing MiR-4262

Angiotensin-Converting Enzyme 2 Inhibits Apoptosis of Pulmonary Endothelial Cells During Acute Lung Injury Through Suppressing MiR-4262

Background/Aims: Angiotensin converting enzyme 2 (ACE2) treatment suppresses the severity of acute lung injury (ALI). The effects of ACE2 in ALI have been shown to not only result from its antagonizing hydrolyzing angiotensin II (AngII), which is responsible for reduction in the vascular tension and...

Full description

Bibliographic Details
Main Authors:	Hong Bao, Fengying Gao, Guogang Xie, Zhenwei Liu
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2015-09-01
Series:	Cellular Physiology and Biochemistry
Subjects:	MiR-4262 Bcl-2 Acute lung injury (ALI) Angiotensin converting enzyme 2 (ACE2) Hydrolyzing angiotensin II (AngII)
Online Access:	http://www.karger.com/Article/FullText/430393

Similar Items

Angiotensin-Converting Enzyme 2 Inhibits Apoptosis of Pulmonary Endothelial Cells During Acute Lung Injury Through Suppressing SMAD2 Phosphorylation
by: Yong Ji, et al.
Published: (2015-04-01)

Recombinant neuraminidase pseudotyped baculovirus: a dual vector for delivery of Angiotensin II peptides and DNA vaccine
by: Irisa Trianti, et al.
Published: (2018-10-01)

The Renin–Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic
by: Marco Prato, et al.
Published: (2024-03-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences
by: Minela Aida Maranduca, et al.
Published: (2022-09-01)

P.30 Angiotensin II Infusion Leads to Aortic Dissection in LRP8 Deficient Mice
by: Jeremy Lagrange, et al.
Published: (2020-12-01)

Zebrafish Model to Study Angiotensin II-Mediated Pathophysiology
by: Bhagyashri Joshi, et al.
Published: (2021-11-01)

Evidence of Renin–Angiotensin System Receptors in Deep Fascia: A Role in Extracellular Matrix Remodeling and Fibrogenesis?
by: Carmelo Pirri, et al.
Published: (2022-10-01)

Angiotensin II: immunohistochemical study in Sardinian pterygium
by: P. Demurtas, et al.
Published: (2014-07-01)

The Embryonic Chick Femur Organotypic Model as a Tool to Analyze the Angiotensin II Axis on Bone Tissue
by: Thais Francini Garbieri, et al.
Published: (2021-05-01)

Angiotensin-converting enzyme 2. Approaches to pathogenetic therapy of COVID-19
by: Polina O. Shatunova, et al.
Published: (2020-09-01)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
by: Oghenemega Okoloko, et al.
Published: (2021-11-01)

Mechanism Underlying Triple VEGFR Inhibitor Tivozanib-Induced Hypertension in Mice Model
by: Wael A. Alanazi, et al.
Published: (2023-02-01)

miR-30a inhibits autophagy of rat cardiomyocyte line H9c2 induced by angiotensin 2
by: YU Tian-le, MA Han, WU Xin-hua, CHEN Zhang-rong, SUN Biao, PENG Yuan, LIU Hong
Published: (2021-04-01)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
by: O. K. Vikulova, et al.
Published: (2020-08-01)

Advance in Research of Angiotensin II and Its Receptor and Malignant Tumor
by: Lulu SUN, et al.
Published: (2016-09-01)

Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
by: Rami Sommerstein, et al.
Published: (2020-04-01)

The Effect of Local Renin Angiotensin System in the Common Types of Cancer
by: Moudhi Almutlaq, et al.
Published: (2021-09-01)

Circulating Soluble ACE2 Plays an Independent Role to Protect against Vascular Damage in Diabetic Mice
by: Chris Tikellis, et al.
Published: (2022-05-01)

Increased angiotensin-converting enzyme activity in the left ventricle after infarction
by: V.C.W. Busatto, et al.
Published: (1997-05-01)

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
by: Rinaldo Bellomo, et al.
Published: (2020-02-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)

Investigating the Relationship Between High Levels of Angiotensin II in Plasma and the Rate of Deterioration in Hypertensive Patients to COVID-19
by: Mina Shahnazari, et al.
Published: (2023-03-01)

Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases
by: Aditi D. Kunvariya, et al.
Published: (2023-05-01)

The Role of Nrf2 in the PM-Induced Vascular Injury Under Real Ambient Particulate Matter Exposure in C57/B6 Mice
by: Mengyu Gao, et al.
Published: (2021-02-01)

Some Aspects of the Renin-Angiotensin-System in Hemodialysis Patients
by: Umar Malik, et al.
Published: (2015-11-01)

Interplay Between Angiotensin II Type 1 Receptor and Thrombin Receptor Revealed by Bioluminescence Resonance Energy Transfer Assay
by: Isra Al Zamel, et al.
Published: (2020-08-01)

S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
by: Reza Nejat, et al.
Published: (2023-01-01)

Urgent need for evaluating agonists of angiotensin-(1-7)/Mas receptor axis for treating patients with COVID-19
by: Ashwini Shete
Published: (2020-07-01)

Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2020-09-01)

Alternative pathways for angiotensin II generation in the cardiovascular system
by: C. Becari, et al.
Published: (2011-09-01)

The renin-angiotensin system and its blockers
by: Igić Rajko, et al.
Published: (2014-01-01)

Corrigendum: Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2021-05-01)

Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension
by: A A Khadartsev, et al.
Published: (2017-12-01)

Expression of Components of the Renin-Angiotensin System by the Putative Stem Cell Population Within WHO Grade I Meningioma
by: Ganeshwaran Shivapathasundram, et al.
Published: (2019-05-01)

Angiotensin 1-7 receptor and angiotensin ii receptor 2 blockades prevent the increased serum and kidney nitric oxide levels in response to angiotensin ii administration: Gender-related difference
by: Tahereh Safari, et al.
Published: (2013-01-01)

Hemorphins Targeting G Protein-Coupled Receptors
by: Mohammed Akli Ayoub, et al.
Published: (2021-03-01)

Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?
by: Shakhi Shylesh C.M, et al.
Published: (2022-01-01)

Studying the Roles of the Renin–Angiotensin System in Accelerating the Disease of High-Fat-Diet-Induced Diabetic Nephropathy in a db/db and ACE2 Double-Gene-Knockout Mouse Model
by: Cheng-Yi Chen, et al.
Published: (2023-12-01)